SLC6A3 and Alzheimer disease: Third, the PPMI cohort provides a wide range of outcomes that capture functional markers of PD, such as executive function, motor score and dopamine transporter activity, and functional and pathological markers of AD, such as episodic memory and CSF Aβ42 levels.